NO165190C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyletanol-aminotetraliner med lipolytisk aktivitet. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyletanol-aminotetraliner med lipolytisk aktivitet.

Info

Publication number
NO165190C
NO165190C NO862773A NO862773A NO165190C NO 165190 C NO165190 C NO 165190C NO 862773 A NO862773 A NO 862773A NO 862773 A NO862773 A NO 862773A NO 165190 C NO165190 C NO 165190C
Authority
NO
Norway
Prior art keywords
phenyletanol
aminotetralines
preparation
therapeutic active
lipolytic activity
Prior art date
Application number
NO862773A
Other languages
English (en)
Norwegian (no)
Other versions
NO165190B (no
NO862773L (no
NO862773D0 (no
Inventor
Roberto Cecchi
Robert Boigegrain
Alberto Bianchetti
Elena Poggesi
Tiziano Croci
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8510559A external-priority patent/FR2584712B1/fr
Priority claimed from FR8606626A external-priority patent/FR2598410B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO862773D0 publication Critical patent/NO862773D0/no
Publication of NO862773L publication Critical patent/NO862773L/no
Publication of NO165190B publication Critical patent/NO165190B/no
Publication of NO165190C publication Critical patent/NO165190C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO862773A 1985-07-10 1986-07-09 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyletanol-aminotetraliner med lipolytisk aktivitet. NO165190C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8510559A FR2584712B1 (fr) 1985-07-10 1985-07-10 Phenylethanolamines a activite lipolytique, un procede pour leur preparation et compositions pharmaceutiques en contenant
FR8606626A FR2598410B1 (fr) 1986-05-07 1986-05-07 Phenylethanolamines optiquement actives, un procede pour leur preparation et compositions pharmaceutiques en contenant

Publications (4)

Publication Number Publication Date
NO862773D0 NO862773D0 (no) 1986-07-09
NO862773L NO862773L (no) 1987-01-12
NO165190B NO165190B (no) 1990-10-01
NO165190C true NO165190C (no) 1991-01-09

Family

ID=26224609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862773A NO165190C (no) 1985-07-10 1986-07-09 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyletanol-aminotetraliner med lipolytisk aktivitet.

Country Status (18)

Country Link
US (1) US4707497A (fi)
EP (1) EP0211721B1 (fi)
JP (1) JPS6263549A (fi)
KR (1) KR940007739B1 (fi)
AR (1) AR241014A1 (fi)
AT (1) ATE46900T1 (fi)
AU (1) AU596976B2 (fi)
CA (1) CA1260493A (fi)
DE (1) DE3666036D1 (fi)
DK (1) DK167353B1 (fi)
ES (1) ES2002717A6 (fi)
FI (1) FI85692C (fi)
GR (1) GR861764B (fi)
IE (1) IE59399B1 (fi)
IL (1) IL79323A (fi)
NO (1) NO165190C (fi)
NZ (1) NZ216793A (fi)
PT (1) PT82930B (fi)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623941A1 (de) * 1986-07-16 1988-01-28 Bayer Ag Substituierte amino-5,6,7,8-tetrahydronaphthyl-oxyessigsaeuren, verfahren zu deren herstellung sowie die verwendung als arzneimittel
US5153225A (en) * 1986-12-10 1992-10-06 Bayer Aktiengesellschaft Substituted basic 2-aminotetralin in pharmaceuticals
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
IT1199339B (it) * 1986-12-23 1988-12-30 Sigma Tau Ind Farmaceuti N-alchil derivati della 2-ammino-6,7-dimetossi tetralina,procedimenti per la loro preparazione e composizioni farmaceutiche ad attivita'an tiipertensiva che li contengono
FR2632636B1 (fr) * 1988-06-14 1991-03-22 Midy Spa Procede pour la preparation de phenylethanolaminotetralines
US5235103A (en) * 1987-08-12 1993-08-10 Sanofi Process for the preparation of phenylethanolaminotetralins
ES2045164T3 (es) * 1987-08-12 1994-01-16 Sanofi Elf Procedimiento para la preparacion de feniletanolaminotetralinas.
FR2619379B1 (fr) * 1987-08-12 1990-01-12 Midy Spa Procede pour la o-alkylation de n-(hydroxy) aralkyl-phenylethanolamines
FR2629453B1 (fr) * 1988-03-30 1990-10-05 Midy Spa Procede pour la preparation de phenylethanolaminotetralines
US5198586A (en) * 1987-08-12 1993-03-30 Sanofi Process for the preparation of phenylethanolaminotetralins
FR2619378B1 (fr) * 1987-08-12 1989-12-15 Midy Spa Procede pour la preparation de phenylethanolaminotetralines
EP0303546B1 (fr) * 1987-08-12 1994-12-28 Sanofi Procédé pour la O-alkylation de N-(hydroxy)aralkylphényléthanolamines
FR2632637B1 (fr) * 1988-06-14 1990-10-12 Midy Spa Ethers de la 2-amino-7-hydroxytetraline
FR2619718B1 (fr) * 1987-09-02 1991-07-12 Medibrevex Nouvelles formes galeniques de beta-2-mimetiques pour administration par voie per- et sublinguale
CA1331191C (en) * 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
US5202466A (en) * 1988-06-14 1993-04-13 Sanofi 2-amino-7-hydroxytetraline ethers
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
FR2648042B1 (fr) * 1989-06-13 1994-06-10 Midy Spa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
IT1230931B (it) * 1989-06-27 1991-11-08 Chiesi Farma Spa Derivati di 2 ammino 1,2,3,4 tetraidronaftalene ad attivita' cardiovascolare, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
FR2653765B1 (fr) * 1989-10-31 1993-08-06 Midy Spa Procede pour la preparation enantioselective de 2-aminotetralines.
IE65511B1 (en) * 1989-12-29 1995-11-01 Sanofi Sa New phenylethanolaminomethyltetralins
FR2656607B1 (fr) * 1989-12-29 1994-03-11 Midy Spa Phenylethanolaminomethyltetralines.
FR2669821A1 (fr) * 1990-12-04 1992-06-05 Sanofi Sa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
EP0499755A1 (fr) * 1991-02-18 1992-08-26 MIDY S.p.A. Nouvelles phényléthanolaminotétralines, procédé pour leur préparation, intermédiaires dans ce procédé et compositions pharmaceutiques les contenant
GB9107827D0 (en) * 1991-04-12 1991-05-29 Fujisawa Pharmaceutical Co New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL104567A (en) * 1992-02-03 1997-03-18 Fujisawa Pharmaceutical Co Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DK0608568T3 (da) * 1993-01-29 1998-09-28 American Cyanamid Co Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler
EP0627407A1 (fr) * 1993-05-28 1994-12-07 MIDY S.p.A. Acide (7S)-7-[(2R)-2(3-chlorophényl)-2-hydroxyéthylamino]-5,6,7,8-tétrahydronaphtalèn-2-yloxy acétique, ses sels pharmaceutiquement acceptables, à action agoniste bêta-3 adrénergique et compositions pharmaceutiques le contenant
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5491134A (en) * 1994-09-16 1996-02-13 Bristol-Myers Squibb Company Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
US6197993B1 (en) 1996-07-02 2001-03-06 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient
JP3909864B2 (ja) * 1995-07-26 2007-04-25 小野薬品工業株式会社 ナフチルオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤
US6075040A (en) * 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
EP0827746B1 (en) 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
FR2758723B1 (fr) * 1997-01-28 1999-04-23 Sanofi Sa Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
EP1070046A1 (en) * 1998-04-06 2001-01-24 Fujisawa Pharmaceutical Co., Ltd. Propanolamine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK254975A (da) * 1974-06-12 1975-12-13 Takeda Chemical Industries Ltd Fremgangsmade til fremstilling af aminotetralolforbindelser
DE2803582A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
EP0033789B1 (en) * 1980-01-30 1984-03-07 American Hospital Supply Corporation 2-alpha-methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, its salts, and a process for preparation thereof

Also Published As

Publication number Publication date
NO165190B (no) 1990-10-01
JP5071581B2 (fi) 1993-10-07
US4707497A (en) 1987-11-17
NZ216793A (en) 1990-05-28
KR870001151A (ko) 1987-03-11
JPS6263549A (ja) 1987-03-20
CA1260493A (en) 1989-09-26
AR241014A2 (es) 1991-04-30
ES2002717A6 (es) 1992-04-16
IE861820L (en) 1987-01-10
NO862773L (no) 1987-01-12
FI85692C (fi) 1992-05-25
PT82930A (fr) 1986-08-01
AU596976B2 (en) 1990-05-24
EP0211721A1 (fr) 1987-02-25
DK328586D0 (da) 1986-07-10
FI862907A (fi) 1987-01-11
NO862773D0 (no) 1986-07-09
GR861764B (en) 1986-11-10
IE59399B1 (en) 1994-02-23
DE3666036D1 (en) 1989-11-09
AR241014A1 (es) 1991-04-30
EP0211721B1 (fr) 1989-10-04
ATE46900T1 (de) 1989-10-15
DK167353B1 (da) 1993-10-18
IL79323A (en) 1990-03-19
KR940007739B1 (ko) 1994-08-24
DK328586A (da) 1987-01-11
IL79323A0 (en) 1986-10-31
FI862907A0 (fi) 1986-07-10
AU5988986A (en) 1987-01-15
PT82930B (pt) 1989-01-30
FI85692B (fi) 1992-02-14

Similar Documents

Publication Publication Date Title
NO165190C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyletanol-aminotetraliner med lipolytisk aktivitet.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO164165C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO164295C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO168706C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO853099L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazo-kinoliner.
NO873727D0 (no) Fremgangsmaate for fremstilling av benzoxazoninforbindelser med terapeutisk aktivitet.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.